Who
Angelos M. Stergiou
President and CEO
Company insider
Files Form 4 as: President and CEO, SELLAS Life Sciences Group.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $59K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2017
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —1,065,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —1,065,000 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code J | $281K187,066 at $1.50 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —385,750 at $0.00 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —257,000 at $0.00 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —243,900 at $0.00 | filing |
| 4 Dec 2024filed 5 Dec 2024 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code J | $32K28,289 at $1.13 | filing |
| 22 Jan 2024filed 25 Jan 2024 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —238,500 at $0.00 | filing |
| 22 Jan 2024filed 25 Jan 2024 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —159,000 at $0.00 | filing |
| 6 Dec 2023filed 8 Dec 2023 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code J | $13K12,268 at $1.08 | filing |
| 2 Feb 2023filed 3 Feb 2023 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —217,500 at $0.00 | filing |
| 2 Feb 2023filed 3 Feb 2023 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —58,000 at $0.00 | filing |
| 5 Dec 2022filed 5 Dec 2022 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Sold | $17K6,494 at $2.61 | filing |
| 31 Jan 2022filed 1 Feb 2022 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 31 Jan 2022filed 1 Feb 2022 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 2 Dec 2021filed 3 Dec 2021 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Sold | $13K2,120 at $6.25 | filing |
| 4 Mar 2021filed 8 Mar 2021 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,500 at $0.00 | filing |
| 4 Mar 2021filed 8 Mar 2021 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —19,750 at $0.00 | filing |
| 12 Mar 2020filed 16 Mar 2020 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 12 Mar 2020filed 16 Mar 2020 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
News
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Down – Here's WhySLS · dailypolitical.com · 20 Oct 2026SELLAS Life Sciences Group (NASDAQ:SLS) Stock Falls 11.2% – Should You Sell?SLS · tickerreport.com · 16 Oct 2026
0 headlines in the last 90 days name Angelos M. Stergiou; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.